FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16162911000001106: Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Dec 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57060101000001112 Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57060201000001117 Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) Is a Pramipexole 3.15mg modified-release tablets true Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) Has active ingredient Pramipexole true Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) Has specific active ingredient Pramipexole dihydrochloride monohydrate false Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Pramipexole true Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) Is a Mirapexin true Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) Has specific active ingredient Pramipexole dihydrochloride monohydrate true Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) Has basis of strength substance Pramipexole true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet 3 x 10 tablets Has AMP True Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start